久久精品30_一本色道久久精品_激情综合视频_欧美日韩一区二区高清_好看的av在线不卡观看_国产自产精品_91久久黄色_午夜亚洲福利_欧美黄在线观看_国内自拍一区

Daily reports about the suspect "Xinfu" antibiotic injection which had allegedly caused six deaths by Tuesday were demanded by the Ministry of Health on Wednesday.  

 

A notice released by the ministry demanded that all provincial health departments report cases of adverse reactions to the clindamycin phosphate glucose injection by 4 PM each day. The reports should cover the 24-hour period up to noon on the day of the report, said the notice. 

 

It also requires medical institutions at all levels to report "Xinfu" related cases to provincial drug monitoring centers and provincial health departments as quickly as possible.

 

The ministry banned the use of the drug, produced by the Anhui Huayuan Worldbest Biology Pharmacy Co., a subsidiary of Shanghai Worldbest Co. Ltd., on August 3.

 

Local health departments have been urged to take emergency control measures and to supervise the implementation of the ban in every single medical institution. "Officials will be held accountable if slack supervision of the recall and control work leads to more adverse reaction cases," says the notice.

 

The antibiotic has so far been blamed for the deaths of six people which were reported from the provinces of Hunan, Sichuan, Hebei, Heilongjiang, Shaanxi and Hubei.

 

Severe adverse reactions have occurred after the drug has been taken which include chest, kidney or stomach pains, vomiting and anaphylactic shock.

 

The Adverse Drug Reaction Monitoring Center of the State Food and Drug Administration (SFDA) had received 81 reports of severe reactions to the antibiotic from 10 provinces by Saturday. The SFDA has sent a team of experts to investigate the link between the reactions and the antibiotic injection, the administration said.

 

The Anhui Huayuan Worldbest Biology Pharmacy Co., based in Fuyang City of east China's Anhui Province, said it has recalled 760,000 bottles of the injection by Sunday morning while more than 480,000 had been sealed. 

 

The company produced 3.68 million bottles of the injection in the batch since June and they were sold to 26 provinces, regions and municipalities.

 

(Xinhua News Agency August 10, 2006)